PMID- 28301802 OWN - NLM STAT- MEDLINE DCOM- 20170607 LR - 20191210 IS - 1532-8384 (Electronic) IS - 0010-440X (Linking) VI - 75 DP - 2017 May TI - Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF. PG - 46-52 LID - S0010-440X(17)30002-0 [pii] LID - 10.1016/j.comppsych.2017.02.014 [doi] AB - BACKGROUND: Numerous studies have reported reduced peripheral brain-derived neurotrophic factor (BDNF) in major depression (MD). However, most of these studies used multidimensional depression rating scales, and failed to identify a relationship between BDNF levels and depression severity. Unidimensional scales are a more valid measure of syndrome severity. In these scales, items are ordered in increasing severity, so that as scores increase, syndrome severity increases; thus, each item adds unique information, and items can be totaled to a meaningful sum. The current study used the HAM-D6, a unidimensional measure of depression, to examine if it could identify a correlation between serum BDNF and depression severity. METHODS: Serum BDNF levels and symptom severity were assessed in 163 depressed patients, including those with both unipolar (84.0%) and bipolar (16.0%) depression. The evaluation of depression severity included the total HAM-D17 and 3 subscales, including the HAM-D6. RESULTS: On average, patients presented moderate to severe depression (HAM-D17=21.2+/-5.5). Overall BDNF levels were 60.4+/-22.6ng/mL. The correlation between serum BDNF and depression severity was modest and not different when assessed by the HAM-D6 subscale or the HAM-D17 as a whole (z=0.951; p=0.341), despite being statistically significant for the HAM-D6 (r=-0.185; p=0.019; 95% CI: -0.335 to -0.033), but not for the entire HAM-D17 (r=-0.127; p=0.108; 95% CI: -0.272 to 0.027). CONCLUSION: We could not identify a strong relationship between serum BDNF levels and depression severity using the HAM-D6. This is in concordance with results of previous studies that reported no correlation between these variables, and indicates that the properties of the clinical measures used cannot explain the results these studies. CI - Copyright (c) 2017 Elsevier Inc. All rights reserved. FAU - Caldieraro, Marco A AU - Caldieraro MA AD - Hospital de Clinicas de Porto Alegre, Department of Psychiatry, Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil. Electronic address: mcaldieraro@hcpa.edu.br. FAU - Vares, Edgar A AU - Vares EA AD - Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil. FAU - Souza, Livia H AU - Souza LH AD - Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil. FAU - Spanemberg, Lucas AU - Spanemberg L AD - Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil; Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS), Department of Psychiatry, Porto Alegre, Brazil. FAU - Guerra, Tadeu A AU - Guerra TA AD - Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil. FAU - Wollenhaupt-Aguiar, Bianca AU - Wollenhaupt-Aguiar B AD - Universidade Federal do Rio Grande do Sul (UFRGS), Programa de Pos-Graduacao em Ciencias Biologicas: Bioquimica, Porto Alegre, RS, Brazil. FAU - Ferrari, Pamela AU - Ferrari P AD - Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil. FAU - Nierenberg, Andrew A AU - Nierenberg AA AD - Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. FAU - Fleck, Marcelo P AU - Fleck MP AD - Hospital de Clinicas de Porto Alegre, Department of Psychiatry, Porto Alegre, Brazil; Universidade Federal do Rio Grande do Sul (UFRGS), Department of Psychiatry and Forensic Medicine, Programa de Pos-Graduacao Ciencias Medicas: Psiquiatria, Porto Alegre, Brazil. LA - eng PT - Evaluation Study PT - Journal Article DEP - 20170306 PL - United States TA - Compr Psychiatry JT - Comprehensive psychiatry JID - 0372612 RN - 0 (Biomarkers) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adult MH - Biomarkers/blood MH - Bipolar Disorder/*blood/psychology MH - Brain-Derived Neurotrophic Factor/*blood MH - Depressive Disorder, Major/*blood/psychology MH - Female MH - Humans MH - Male MH - Middle Aged MH - *Psychiatric Status Rating Scales MH - *Severity of Illness Index EDAT- 2017/03/17 06:00 MHDA- 2017/06/08 06:00 CRDT- 2017/03/17 06:00 PHST- 2017/01/03 00:00 [received] PHST- 2017/02/27 00:00 [revised] PHST- 2017/02/28 00:00 [accepted] PHST- 2017/03/17 06:00 [pubmed] PHST- 2017/06/08 06:00 [medline] PHST- 2017/03/17 06:00 [entrez] AID - S0010-440X(17)30002-0 [pii] AID - 10.1016/j.comppsych.2017.02.014 [doi] PST - ppublish SO - Compr Psychiatry. 2017 May;75:46-52. doi: 10.1016/j.comppsych.2017.02.014. Epub 2017 Mar 6.